The Tyrant Billionaire

Chapter 637 Hans Pharmaceuticals stock price collapse



"And through several offshore financial companies and hundreds of accounts, we shorted a total amount of over $12 million with 20x leverage. The expected profit is around $125 million," Andy said with a grin.

Goodness, If everything goes smoothly, this operation could bring in over $100 million again.

However, this would certainly ruin a lot of people.

Capitalists are insatiable like this, greedily sucking the blood and flesh of others. Their growth is paved with the bones of countless victims.

"So, what's your next move?" Hardy asked Andy.

"Actually, we don't need to do anything now. Just wait for the market to react. Such big news will have people digging into it nonstop, eventually causing a full blown explosion," Andy replied.

Hardy nodded.

During this period, he decided to stay in the U.S. and enjoy the show.

When he returned to the estate, he called the French girl Irina to come over. It had been a long time since he'd seen her, and this time, he decided to prioritize her. To be fair, her legs were the best among all the women Hardy had.

The Los Angeles Financial Times suddenly broke a massive story about "Hans Pharmaceuticals," causing an instant stock market uproar. Hans Pharmaceuticals initially experienced a panic driven plunge, but it stabilized shortly after. After all, it was still just a rumor and hadn't been confirmed.

Even so, the market's trust had already been shaken.

However, no one was willing to buy Hans Pharmaceuticals' shares anymore. The only reason its stock price remained stable was that those holding the shares didn't want to sell, and there were no buyers in the market, effectively locking the price in place.
Read latest stories on My Virtual Library Empire

This issue, caught the attention of the U.S. stock market, and the Japanese side was equally focused on it.

Various news outlets reported on the situation, triggering fear among many Japanese investors. Those in the know understood that Japanese financial companies had invested significant amounts of money into Hans Pharmaceuticals.

If Hans Pharmaceuticals' stock crashed, their investments would be wiped out.

As a result, a lot of people were growing extremely anxious during this time.

Two days later, Hardy woke up and prepared to exercise. Elizabeth Taylor was still sound asleep in bed. The previous night, Hardy had thoroughly "taken care" of her, leaving her so exhausted that she couldn't wake up in the morning.

After completing his workout in the gym and taking a shower, Hardy came to the dining room for breakfast. While eating, he read the newspaper.

Today'sNew York Timeshad also published a report on Hans Pharmaceuticals, with content even more explosive than the previous days.

"Confirmed: Hans Pharmaceuticals Committed Fraud; African Officials Verify Poor Results in Their Human Drug Trials."

"The New York Times' Africa Bureau found the site where Hans Pharmaceuticals conducted its human trials. Local officials revealed that they conducted a surprise inspection of Hans Pharmaceuticals' experiments and discovered that the company wasn't simply using the reported drug, 'Ethambutol.' Instead, they combined 'Ethambutol' with 'Streptomycin.' Since it's unclear which drug produced the effects, all experimental data from Hans Pharmaceuticals has been deemed invalid, requiring them to redo their experiments."

"Hans Pharmaceuticals had previously marketed 'Ethambutol' as a wonder drug. Why, then, was it used in combination with Streptomycin? This is clearly fraudulent. We strongly suspect that Hans Pharmaceuticals' actions were solely to inflate their stock price and deceive investors."

"We also interviewed former researchers from Hans Pharmaceuticals. Several of them disclosed that prior to Dr. Hans announcing his discovery of a tuberculosis miracle cure, many of Hans Pharmaceuticals' projects had stalled. Its stock price had plummeted, and the company had borrowed heavily from banks, plunging into financial trouble. Projects were entirely suspended, and many salaries were still unpaid. It was at this time that Dr. Hans suddenly claimed to have found the tuberculosis miracle cure, causing the stock price to soar wildly. Based on this series of actions, there are strong suspicions of fraud."

Following this report, Hans Pharmaceuticals' stock, which had held on for two days, entered a free fall, plummeting uncontrollably. Unlike in some countries, the U.S. stock market is completely free and does not impose trading halts, so Hans Pharmaceuticals' drop resembled a waterfall, plunging to new lows.

Hans Pharmaceuticals had always been a concept stock. People bought it based on the expectation of its success. Once it succeeded, it would have a vast market and immense profitability, which is why people were willing to invest in it.

Of course, the reason Hans Pharmaceuticals reached such a high stock price was largely due to market speculation. Even for a promising concept stock, its price should never have soared so high.

This couldn't have happened without Andy's brilliance and the earlier groundwork laid out, turning a mere speculative stock into an A-tier stock.

By the time the market closed, Hans Pharmaceuticals' stock had dropped from over $80 per share to $20 per share, shrinking by four fifths from its peak.

Hardy knew this wasn't the end.

The next day,The Los Angeles Timesreported again, stating that Hans Pharmaceuticals had caught the attention of the Securities and Exchange Commission (SEC), which had decided to investigate the company. If fraud was confirmed, Hans Pharmaceuticals could face suspension and legal consequences for those responsible.

Holders of Hans Pharmaceuticals' stock were shaken to their core.

Legal accountability? That's of no use to them.

What they wanted was money.

If the stock was suspended, the shares in their hands would become worthless, turning into nothing more than scraps of paper. Many people rushed to the stock market, frantically selling off their shares.

But at that point, who would be foolish enough to play the bagholder?

As panic spread, Hans Pharmaceuticals' stock price plummeted further, closing at just $3 per share.

A year's hard work, wiped out in three days.

And yet, this wasn't the bottom.

In the stock market, there is no bottom—only lower and lower, until the depths are unfathomable.

---


Tip: You can use left, right, A and D keyboard keys to browse between chapters.